References

1. Kyle RA: Multiple myeloma. Review of 869 cases. Mayo Clin Proc 50:29, 1975.

2. Kyle RA, Gertz MA, Witzig TE, et al.: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21, 2003.

3. Riccardi A, Gobbi PG, Ucci G, et al.: Changing clinical presentation of multiple myeloma. Eur J Cancer 27:1401, 1991.

4. Blade J, Kyle RA, Greipp PR: Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol 93:345, 1996.

5. Rodon P, Linassier C, Gauvain J-B, et al.: Multiple myeloma in elderly patients: presenting features and outcome. Eur J Haematol 66:11, 2001.

6. Knudsen LM, Hippe E, Hjorth M, et al.: Renal function in newly diagnosed multiple myeloma—a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol 53:207, 1994.

7. Blade J, Fernandez-Llama P, Bosch F, et al.: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158:1889, 1998.

8. DeFronzo RA, Humphrey RL, Wright JE, et al.: Acute renal failure in multiple myeloma. Medicine 54:209, 1975.

9. DeFronzo RA, Cooke CR, Wright JR, et al.: Renal function in patients with multiple myeloma. Medicine 57:151, 1978.

10. Cohen DJ, Sherman WH, Osserman EF, et al.: Acute renal failure in patients with multiple myeloma. Am J Med 76:247, 1984.

11. Pringle JP, Graham RC, Bernier GM: Detection of myeloma cells in the urine sediment. Blood 43:137, 1974.

12. Means RT Jr: Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem cell 13:32, 1995.

basic biology of the immune system. Continued research in this area promises to refine our understanding of these disorders and, more importantly, will identify molecular targets for the next generation of effective therapeutics.

0 0

Post a comment